Jeffrey W. Jacobs, Chief Scientific Officer at ARDELYX, INC. (ARDX), sold 3,949 shares at $6.88 ($27K) on 2020-12-21, disclosed to the SEC on 2020-12-22.
Scheduled sale ($27k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ARDX | SELL | 2021-11-10 | $3K | — | Filing → |
| ARDX | SELL | 2021-08-24 | $978 | — | Filing → |
| ARDX | SELL | 2021-06-17 | $55K | — | Filing → |